ClinicalTrials.gov
public full text
Public Domain
A Phase I Study of SNH-119014 in Healthy Volunteers
SNH-119014 is an oral small-molecule agonist of pyruvate kinase red blood cell isozyme (PKR) being developed for the treatment of hemolytic anemias. This initial study will characterize the safety, tolerability and the pharmacokinetics/pharmacodynamics (PK/PD) of a single ascending dose and multiple ascending doses of SNH-119014 in the context of Phase 1 studies in healthy volunteers. The effects of food on the absorption of SNH-119014 will also be evaluated in healthy volunteers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects#894530
- Effect of Hepatic Impairment on LDK378 Pharmacokinetics#875702
- Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation#979093
- A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)#982355
- Comparison of HBW-3220 Capsule Formulations and the Effect of Food in Healthy Participants#825016
Record · ID 979290
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive